Anna Maria B. I.
- Country
- Spain
- Department
- Radiotherapy oncology service
Research Overview
- Phase 3 Randomized, Double-blind, Placebo-controlled Study of Apalutamide and GnRH Agonist in High-risk Localized or Locally Advanced Prostate Cancer with Primary Radiation Therapy
- Comparison of Short- and Long-term Androgen Deprivation Therapy with Salvage Radiotherapy in Prostate Cancer Recurrence: A Phase III Randomized Trial
Data & Insights
Has run more than one trial at 6 of 97 partner sites.
Specializations
Advanced Prostate Cancer Management
Specializes in treating high-risk localized and locally advanced prostate cancer through integrated therapeutic approaches combining radiation therapy and hormone treatments.
- Primary radiation therapy optimization
- GnRH agonist treatments
- Metastasis-free survival strategies
Utilizes advanced imaging techniques including PSMA-PET for treatment monitoring and evaluation.
Post-Surgical Cancer Care
Focuses on salvage radiotherapy treatments for patients experiencing prostate cancer recurrence following surgical intervention, with particular attention to hormone therapy duration optimization.
- Androgen deprivation therapy protocols
- Post-surgical radiation planning
- Long-term survival outcomes
Evaluates comparative effectiveness of varying durations of hormone therapy in conjunction with radiation treatments.
Oligometastatic Disease Treatment
Specializes in managing oligometastatic castration-resistant prostate cancer through precise stereotactic radiotherapy combined with advanced hormone therapies.
- Stereotactic body radiation therapy
- Second-generation antiandrogen applications
- PET/CT-guided treatment planning
Implements innovative multimodal approaches using targeted radiation and hormone therapy combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.